Register
Login

Trending Topic

11 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Lung cancer is the second most common type of cancer worldwide and in the USA, with its incidence varying depending on geographic and socioeconomic factors.1–3 According to data from the Global Cancer Observatory: Cancer Incidence, Mortality and Prevalence (GLOBACAN) database, an estimated 2.48 million new cases of lung cancer were reported in 2022.4,5 Although lung cancer rates in the […]

Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 18th 2021

We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign.

Questions
1. What has been the impact of the COVID-19 pandemic on cancer screening and care? (00:20-01:55)
2. What are the objectives of the Time to Act campaign? (01:55-03:18)
3. What are the three key messages in this campaign? (03:18-04:38)
4. What resources are available as part of this campaign? (04:38-05:55)

Speaker Disclosure: Prof Mark Lawler has received honoraria from Pfizer, EMD Serono, Roche and Canall Farrar. This funding is unrelated to this work.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the European Cancer Summit 2021

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup